Events

InvestAcure, PBC, honored 10 leading bioindustry scientists with the Cure Coin Award for their outstanding work developing groundbreaking scientific discoveries into lifesaving therapeutics for Alzheimer’s, CTE and other related Dementias.

Hospital Management Asia 2019, the annual event for Asian healthcare leaders, will be held September 11-12, 2019, at the National Convention Centre of Vietnam.

Eisai Co., Ltd. announced the presentation and discussion about the treatment, including oral beta amyloid cleaving enzyme (BACE) inhibitor elenbecestat(1) research data on Alzheimer’s disease(AD), were given in the AAIC’s Focused Topic Session “Discussion of BACEi Trial Findings: Challenges and Opportunities” at the Alzheimer’s Association International Conference (AAIC) held in Los Angeles, California, United States, from July 14 to 18, 2019.

In Cerebrospinal Fluid and the Identification of a Target Engagement Biomarker for the New Anti-Tau Antibody E2814 at Alzheimer’s Association International Conference (AAIC) 2019

Here’s a look at the top clinical trial news from last week, with updates from Neon, GSK, Biohaven, and more.

It was a big week for Alzheimer’s research as researchers from around the world descended on Los Angeles to attend the Alzheimer’s Association International Conference (AAIC) this week. Here’s a look at some of the stories you may have missed.

On July 16, 2019, tech entrepreneur Elon Musk presented his vision for high-bandwidth brain-machine interfaces to connect humans and computers with help from XVIVO Scientific Animation, a leading scientific and medical animation studio based in Connecticut

Without Significant Effects on Synaptic Function in Brain by Spinal Densitiy Evaluation at Effective Dose to Decrease Amyloid Beta Level in Cerebrospinal Fluid at Alzheimer’s Association International Conference (AAIC) 2019

Assertio Therapeutics, Inc. announced that it will release second quarter 2019 financial results on Wednesday, August 7, 2019, after the close of markets.

GeoVax Labs, Inc. announced that Senior Scientist, Mugdha Vasireddi, PhD, will deliver an oral presentation entitled, A Single Dose of MVA-Based Lassa Virus Vaccine Provides Complete Protection in a Mouse Lethal Challenge Model.